Search for a command to run...
Adline Chem Lab Ltd. is significantly underperforming compared to its peers, with no revenue growth, negative valuation metrics, and zero profitability. In contrast, companies like Dr. Reddy's Laboratories and Cipla Ltd. are leading in profitability and growth, making them strong picks. Sun Pharma, despite being a market leader, is potentially overvalued based on its PE ratio.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Adline Chem Lab Ltd. | ₹17.24 | ₹10.09Cr | -76.28 | - | - |
SUNPHARMA | ₹1,563.35 | ₹3,75,099.26Cr | 87.59 | 17.60% | 0.04 |
DIVISLAB | ₹6,091.05 | ₹1,61,698.50Cr | 73.20 | 16.46% | - |
CIPLA | ₹1,587.60 | ₹1,28,217.27Cr | 23.73 | 22.77% | 0.01 |
TORNTPHARM | ₹3,581.55 | ₹1,21,215.77Cr | 61.53 | 24.28% | 0.57 |
DRREDDY | ₹1,280.30 | ₹1,06,835.27Cr | 15.50 | 26.86% | 0.07 |
MANKIND | ₹2,518.95 | ₹1,03,926.59Cr | 55.18 | 28.38% | 0.02 |